Effect of an interferon stimulator, polyinosinic: polycytidylic acid, on experimental fungus infections

Infection and Immunity
|February 1, 1972
PubMed

Insights

Polyinosinic:polycytidylic acid (In:Cn), an interferon stimulator, worsened experimental fungal infections in mice. In:Cn treatment led to increased mortality and fungal burden for Candida albicans and Coccidioides immitis infections.

Area of Science:

  • Immunology
  • Mycology
  • Infectious Diseases

Background:

  • Interferon stimulators modulate immune responses.
  • Fungal infections pose significant health challenges.

Purpose of the Study:

  • To investigate the effect of polyinosinic:polycytidylic acid (In:Cn) on experimental fungal infections.
  • To determine if In:Cn influences the severity of Candida albicans, Coccidioides immitis, and Cryptococcus neoformans infections.

Main Methods:

  • Administration of In:Cn to mice prior to fungal challenge.
  • Monitoring survival rates and mortality.
  • Quantifying fungal burden in infected tissues (kidneys).

Main Results:

  • In:Cn treatment significantly increased mortality and fungal burden in mice infected with Candida albicans and Coccidioides immitis.
  • Kidney tissue fungal load for Candida albicans was 40- to 300-fold higher in In:Cn treated mice.
  • Cryptococcus neoformans infection severity was not significantly altered by In:Cn treatment.

Conclusions:

  • In:Cn exacerbates certain experimental fungal infections in mice.
  • The impact of In:Cn on fungal infections may be pathogen-specific.
  • Further research is needed to understand the mechanisms behind In:Cn's differential effects.